Clinical Study Results
What serious adverse events did the participants have?
The table below shows the serious adverse events that the participants had during this study.
Serious adverse events
Part A Part B
Serious Group 1 Group 2 Group 3 Group 4 Group 5 Group 6 Group 7
adverse (out of 6 (out of 6 (out of 6 (out of 6 (out of 6 (out of 7 (out of 17
events participants) participants) participants) participants) participants) participants) participants)
Sepsis 0.0% (0) 0.0% (0) 16.7% (1) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
Urinary tract
0.0% (0) 16.7% (1) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
infection
Fever and low
white blood
16.7% (1) 16.7% (1) 16.7% (1) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
cell count,
neutrophils
Stroke 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 5.9% (1)
Disease of
0.0% (0) 0.0% (0) 16.7% (1) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
heart valve
Blockage in a
0.0% (0) 0.0% (0) 16.7% (1) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
blood vessel
Build-up of
protein-rich
16.7% (1) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
fluid in the
abdomen
Inflammation
0.0% (0) 0.0% (0) 16.7% (1) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
of the colon
Difficulty
16.7% (1) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
swallowing
Rash 0.0% (0) 16.7% (1) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
Chest
0.0% (0) 0.0% (0) 16.7% (1) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
discomfort
Chest pain 0.0% (0) 16.7% (1) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
11 participants died during the study. All the deaths were due to the worsening of
participantsâ€™ disease. There were no treatment-related deaths during this study.
7